10.71USD-0.19%Mkt Cap: 141.93M USDP/E: 59.502d ago
Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was founded in 1995 and is headquartered in Los Angeles, California.…
OACCOaktree Acquisition Corp. III Life Sciences10.71USD-0.19%
About Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACC)
›
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACC) is listed on Nasdaq, where its shares trade in USD. It belongs to the Shell Companies industry, part of the Financial Services sector.
The shares were at 10.71 USD on 20 November 2026, up 1.1% over 52 weeks.
At a market capitalisation of 141.93M USD, it trades at 59.5 times trailing earnings. The median trailing P/E of its 5 largest Shell Companies peers is 36.0, a premium of 65% for OACC.
Oaktree Acquisition Corp. III Life Sciences reports return on equity of 3.7% and an operating margin of 0.0%.
It holds more cash than debt, a net cash position of 1.17M USD. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health.